An Open-Label Phase II Study Assessing the Safety of Bilateral, Sequential Administration of Retinal Gene Therapy in Participants with Choroideremia: The GEMINI Study

Overview of attention for article published in Human Gene Therapy, August 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,401 followers.

RT @HGTJournal: GEMINI study: bilateral gene therapy for choroideremia was well tolerated without significant immune response. Read the ful…

GEMINI study: bilateral gene therapy for choroideremia was well tolerated without significant immune response. Read the full research article: https://t.co/rf9BodbZti

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.